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Abstract  Clinical  examination  of  the  nipple  is  part  of  normal  breast  screening  procedures.
Abnormal processes  of  benign  or  malignant  nature  may  be  reﬂected  by  erythema,  erosion,
swelling or  acquired  inversion.  In  patients  presenting  with  a  persistent  unilateral  nipple  lesion,
it is  advisable  to  collect  a  sample  to  exclude  Paget’s  disease  of  the  nipple,  a  rare  form  of  ductal
carcinoma  in  situ  (DCIS).  Imaging  should  be  performed  to  detect  breast  cancer,  which  is  found  in
more than  80%  of  cases,  and  determine  its  possible  multifocal  nature.  Breast  MRI  is  indicated  if
breast-conserving  surgery  is  planned.  The  main  differential  diagnoses  are  erosive  adenomatosis
and eczema  of  the  nipple.  Acquired  inverted  nipple  is  generally  of  inﬂammatory  origin.  It  is
usually diagnosed  by  conventional  breast  examination  but  breast  MRI  can  be  helpful  when  in
doubt about  possible  underlying  neoplasia.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
Introduction
Clinical  assessment  of  the  nipple-areola  complex  (NAC)  is  a  normal  part  of  breast  screening
procedures.  Clinical  changes  such  as  erythema,  erosion,  swelling  or  retraction  of  the  breast
may  be  signs  of  a  process  of  benign  or  malignant  nature.  Radiologists  should  therefore  be
familiar  with  the  main  diagnoses  that  can  be  made  as  well  as  the  imaging  ﬁndings  for  each
condition.
We  shall  successively  review  the  conditions  that  cause  superﬁcial  changes  to  the  NAC
and  acquired  nipple  inversions.
Abbreviations: EAN, erosive adenoma of the nipple; NST-WHO 2012, Invasive carcinoma of no special type according to the 2012 WHO
Classiﬁcation; MRI, magnetic resonance imaging; NAC, nipple-areola complex; DCIS, ductal carcinoma in situ.
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demonstrated  that,  even  when  the  pathological  grade  and034  
uperﬁcial changes of the nipple-areola
omplex
aget’s disease of the nipple
aget’s  disease  of  the  nipple  is  often  diagnosed  at  a late
tage;  6  to  12  months  after  the  ﬁrst  symptoms  appear.
esions  are  practically  always  unilateral.  At  an  early  stage,
he  nipple  is  pruritic,  then  becomes  bright  red  and  shiny.  At
n  intermediate  stage,  the  nipple  becomes  thicker,  rougher
nd  scaly.  Late  stage  Paget’s  disease  manifests  as  nipple
rosion,  with  oozing  ulceration  and  indurated  crusting  with
learly  deﬁned  borders.  Concurrently,  the  nipple  gradually
attens.  The  nipple  extends  centrifugally  and  very  gradually
owards  the  areola  (Fig.  1a—d).  Bloody  and/or  serous  nipple
ischarge  or  the  presence  of  a  palpable  lump  is  associated
ith  the  condition  in  one  to  two  thirds  of  cases  [1—5].
Diagnosis  can  be  made  by  scrape  cytology  of  the  nipple
ut  nowadays  nipple-areolar  punch  biopsies  are  performed
ore  and  more  frequently  because  they  provide  more  rep-
esentative  samples  [6]  (Fig.  2a—d).
Temporary  improvements  have  been  reported,  as  have
igmented  forms  that  mimic  malignant  melanoma  [7].  In
uch  cases,  surgical  biopsy  should  be  favored  over  punch
iopsy.
Paget’s  disease  of  the  nipple  is  characterized  by  inﬁl-
ration  of  the  nipple  epidermis  by  DCIS  cells.  It  accounts  for
ess  than  3%  of  all  breast  tumors  [1,2].  Depending  on  patient
opulations,  the  average  age  at  diagnosis  ranges  from  51  to
0  years  (extreme  values  of  24  and  90  years)  [3—5].
igure 1. Different clinical stages of Paget’s disease of the nipple: a:
ough nipple; c: late stage: scaly, erythematous lesion with ulcerations
he nipple towards the areola, perfectly deﬁned edges and entirely ﬂatt
ource: Imagerie de la femme, sénologie, Anne Tardivon, Éditions Lavois
p
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Histopathological  assessment  reveals  the  presence  of
aget  cells  within  the  epidermis  of  the  nipple  (large  cells
ith  clear  cytoplasm  and  large  irregularly-shaped  hyper-
hromatic  nuclei  that  are  frequently  undergoing  mitotic
ivision).  Two  theories  have  been  developed  to  explain  the
rigin  of  Paget  cells:  ﬁrst,  according  to  the  migratory  theory,
aget  cells  migrate  from  an  underlying  breast  carcinoma.  On
he  other  hand,  the  transformation  theory  holds  that  epi-
ermal  keratinocytes  become  malignant  independent  of  any
ther  malignancy  of  the  breast  [8].
Paget’s  disease  of  the  nipple  is  associated  with  underlying
reast  cancer  in  more  than  80%  of  cases,  both  near  to  and
t  a distance  from  the  NAC  [2,4,5,8—10]  (Figs.  3  and  4a—b).
arcinoma  in  situ  accounts  for  less  than  half  of  the  cases,
nd  invasive  carcinoma  accounts  for  one  to  two  thirds
f  cases  [4,8,10]. Ductal  carcinoma  predominates  [1,10],
lthough  all  histological  types  can  be  observed.
Carcinomas  associated  with  Paget’s  diseases  are  gener-
lly  found  to  be  more  aggressive:  their  histological  grade
s  often  higher,  and  they  are  more  often  hormone-receptor
egative  and  C-erb  2  positive  (80%  of  cases)  than  cancers
hat  are  not  associated  with  Paget’s  disease  [5,9,11,12].
Three  factors  of  poor  prognosis  have  been  described
or  Paget’s  disease:  the  presence  of  a  palpable  lump,
ymph  node  involvement  and  the  invasiveness  of  the  asso-
iated  breast  cancer  [2,3,11].  Nonetheless,  a  recent  study early stage: red, shiny nipple; b: intermediate stage: thickened,
 and nipple ﬂattening; d: very late stage: centrifugal extension of
ened nipple.
ier.
rognostic  factors  are  equivalent,  the  survival  of  patients
ith  invasive  carcinoma  and  Paget’s  disease  of  the  nip-
le  is  lower  than  that  of  patients  with  invasive  cancer  but
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Figure 2. Performing a nipple-areola complex biopsy: a: local anesthesia: application of a superﬁcial anesthetic cream (Emla 5%®) during
1.5 hours; injection of 3—4 mL of lidocaine using a 26-gage needle; b: dermal punch biopsy of the lesion using a 3—4 mm punch; c: collection
of the sample using tweezers; d: post-biopsy wound.
Figure 3. Paget’s disease of the nipple; patient without other
clinical signs of malignancy: breast MRI, MLO view, early subtracted
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ephase images after gadolinium injection; isolated non-speciﬁc
enhancement of the nipple-areola complex; absence of retroareolar
or remote abnormalities.
without  Paget’s  disease  [3],  with  an  overall  survival  at  5
years  of  62.1%  versus  91.8%,  respectively  [13].
First-line  assessment  is  performed  using  mammography
and  breast  ultrasound,  especially  for  dense  breasts,  and  is
aimed  at  detecting  associated  breast  carcinoma  and  guiding
biopsies.The  most  common  mammographic  ﬁndings  are  microcal-
ciﬁcations  (44%)  [4]  which  suggest  DCIS  if  located  within
or  just  under  the  nipple,  whether  punctiform  or  rod-like
along  the  ducts,  or  even  clustered  in  foci  or  arrays.  Lumps,
t
g
s
ikin  thickening  around  the  nipple,  microcalciﬁcations  and
ocal  asymmetric  densities  are  found  in  equal  proportions
approx.  20%  for  each)  [4]  (Fig.  5a—c).
The  sensitivity  of  conventional  imaging  modalities  is  low
hen  it  comes  to  detecting  breast  carcinoma  associated
ith  Paget’s  disease.  A  recent  study  [14]  reported  that
he  sensitivity  of  mammography  and  breast  ultrasound  was
f  79%  and  74%  respectively  for  detecting  invasive  cancer
ut  only  of  39%  and  19%  for  DCIS.  The  performances  of
reast  MRI  are  however  signiﬁcantly  better,  with  a sensitiv-
ty  of  100%  for  inﬁltrating  carcinomas  and  44%  for  carcinoma
n  situ.
In addition,  the  tumors  associated  with  Paget’s  disease
end  to  be  multifocal  and  multicentric,  the  incidence  of
ultifocality  ranging  from  20  to  79%  depending  on  studies
1,2,4,5,9,10].
The  superiority  of  MRI  compared  with  other  conventional
maging  modalities  for  the  detection  of  breast  carcinoma
nd  multifocality  is  well  established  [15,16].  However  there
re  still  no  ofﬁcial  guidelines  that  recommend  the  routine
se  of  breast  MRI  in  Paget’s  disease  [17]. Its  use  should  nev-
rtheless  be  considered  before  planning  for  conservative
reatment  or  when  the  extent  of  associated  tumor  devel-
pment  is  unclear.
In  such  patients  with  a  high  risk  of  breast  cancer,
ll  enhanced  areas  detected  by  MRI  should  be  consid-
red  as  potentially  neoplastic.  If  MRI  shows  an  abnormality
hat  might  affect  the  planned  surgical  strategy,  then  tar-
eted  ultrasound  and/or  additional  mammographic  imaging
hould  be  carried  out  in  the  ﬁrst  instance  in  order  to
dentify  a  lesion  consistent  with  MRI  ﬁndings  and  obtain
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Figure 4. Paget’s disease of the nipple associated with a bilobed mass of the superomedial quadrant corresponding to grade III NST: a:
mammography, CC view; b: breast ultrasound: 2 contiguous masses with spiculated borders.
Figure 5. Paget’s disease of the left nipple. Mammographic imaging (a: CC view; b: LM view; c: magniﬁed CC view): clustered micro-
calciﬁcations in the superolateral quadrant and spiculated mass the inferolateral quadrant; ultrasound-guided biopsy showed grade III
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ercutaneous  tissue  samples.  If  no  consistent  lesions  are
etected  using  ultrasound  or  mammography,  MRI-guided
ampling  or  MRI-guided  marker  placement  prior  to  surgery
hould  be  considered  (Fig.  6a—c).
Surgical  management  is  adjusted  to  tumor  extent  and
ocation.  Minimal  treatment  in  patients  with  Paget’s  disease
hat  has  not  spread  beyond  the  NAC  consists  of  NAC  resection
ogether  with  radiation  therapy  of  the  whole  breast.
Sentinel  lymph  node  biopsy  should  be  performed  when
nvasive  carcinoma  is  diagnosed  prior  to  surgery.  However
n  patients  without  proven  invasive  carcinoma  (isolated
aget’s  disease  or  associated  in  situ  carcinoma),  the  loca-
ion  of  the  sentinel  lymph  node  has  yet  to  be  clearly
stablished  [18].
Adjuvant  therapy,  chemotherapy  and/or  hormone  ther-
py  is  indicated  for  the  type  of  cancer  associated  with
aget’s  disease.
m
differential diagnosis for Paget’s disease of
he nipple
rosive adenomatosis of the nipple (EAN)
his  benign  tumor,  which  develops  within  the  lactiferous
ucts  of  the  nipple,  is  also  called  nipple  adenoma,  ﬂorid
apillomatosis  of  the  nipple,  superﬁcial  papillary  adeno-
atosis  of  the  nipple  or  subareolar  duct  papillomatosis.  It
s  the  main  differential  diagnosis  of  early-stage  Paget’s  dis-
ase  [19].  It  represents  15%  of  all  nipple  tumors  and,  in  97%
f  cases,  occurs  in  premenopausal  women  (extreme  values:
—87  years).  EAN  has  also  been  reported  in  children  and  men
19].The  initial  symptoms  of  EAN  are  nipple  erosion,  inﬂam-
ation,  erythema,  and  a  bloody,  serous  or  serosanguinous
ischarge  (60%  of  cases).  At  a  later  stage,  the  nipple  appears
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Figure 6. Paget’s disease considered as ‘‘normal’’ or ‘‘benign’’ following conventional breast examination. Pre-operative breast MRI;
axial subtracted phase images after gadolinium injection, maximal intensity projection: a: abnormal non-speciﬁc enhancement of the right
nipple-areola complex and two remote non-masslike enhancements that were not detected during targeted breast examination after MRI.
Pathology ﬁndings after MRI-guided biopsy: DCIS; b: abnormal non-speciﬁc enhancement of the left nipple-areola complex with a mass
mass consistent with the one visualized by MRI. Pathology ﬁndings after
avoisier.
Figure 7. Erosive adenoma of the nipple: nodular enlargement of
the nipple.
S
Llocated in the medial quadrants; c: targeted ultrasound detected a 
ultrasound-guided microbiopsy: DCIS.
Source: Imagerie de la femme, sénologie, Anne Tardivon, Éditions L
enlarged  and  becomes  thicker  and  indurated.  Cleary  deﬁned
ulceration  is  also  observed,  as  well  as  oozing  and  sometimes
a  palpable  nodular  mass  located  under  the  nipple  (Fig.  7).
At  this  stage,  it  is  easier  to  differentiate  between  EAN  and
Paget’s  disease  of  the  nipple  [20].  Symptoms  may  be  accen-
tuated  during  the  premenstrual  period.  Bilateral  cases  or
EAN  of  a  supernumerary  nipple  are  very  rare.  The  condition
progresses  slowly  over  months  or  even  years,  and  is  some-
times  marked  by  complications  of  infectious  origin  (breast
abscess,  adenopathies).
Pathological  ﬁndings  show  mixed  benign  adenomatous
and  papillary  proliferation  within  a  lactiferous  sinus  of
the  nipple.  Due  to  the  size  of  the  affected  area,  EAN  is
generally  not  detected  by  mammography  or  ultrasound,
however  sometimes  it  can  be  visualized  as  a  small  oval-
shaped  tissue  mass  contiguous  to  the  nipple  [21].  In  the
same  way,  breast  MRI  is  generally  of  little  use  for  diag-
nosing  EAN.  When  performed,  the  affected  nipple  appears
more  enhanced  than  the  normal  nipple,  and  enhance-
ment  continues  into  the  late  phases  without  wash-out  [22].
No  regions  of  high  intensity  are  observed  on  T2-weighted
images.
EAN  is  treated  by  breast-conserving  techniques  with  com-
plete  excision  of  the  lesion.  Prognosis  is  excellent  but  EAN
c
c
n
eource: Imagerie de la femme, sénologie, Anne Tardivon, Éditions
avoisier.an  recur  if  not  completely  removed.  The  risk  of  breast  car-
inoma  does  not  seem  to  be  increased.  Breast-feeding  is
ot  advised  following  treatment  due  to  the  increased  risk  of
ngorgement.
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Figure 8. Areolar eczema: poorly delimited lesion without crust-
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ing or ulceration. Paget’s disease can be excluded due to the
bsence of nipple involvement.
reast eczema
czema  of  the  nipple-areolar  region  mostly  occurs  in  atopic
atients.  It  is  generally  found  to  be  bilateral,  is  associ-
ted  with  intense  pruritus  but  does  not  deform  the  nipple.
he  affected  area  is  poorly  delimited  with  granular  bor-
ers,  no  crusting  and  no  real  ulceration.  Breast  eczema
rogresses  relatively  rapidly  compared  with  Paget’s  disease
Fig.  8).  Eczema  patients  go  through  periodic  ﬂare-ups  that
l
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igure 9. Nipple-areola complex inﬁltration by a retroareolar carcinom
omplex with periareolar retraction. Punch biopsy scar (dark red spot). 
ass and array of microcalciﬁcations at the boundary between lower q
mages after injection of gadolinium: irregularly-shaped mass inﬁltratingD.  Geffroy,  I.  Doutriaux-Dumoulins
lternate  with  phases  of  remission.  In  some  patients  the
esions  are  chronic  and  become  licheniﬁed.  Eczema  is  also
ound  in  other  locations,  in  particular  the  folds  of  the  skin.
urther  breast  examination  is  not  required  once  eczema  has
een  diagnosed.  However,  if  the  condition  is  both  unilat-
ral  and  chronic,  biopsy  must  be  performed  to  exclude  the
ossibility  of  Paget’s  disease.  Treatment  consists  of  inter-
ittent  local  corticosteroid  therapy  that  rapidly  relieves  the
ymptoms.
uperﬁcial spreading of breast
denocarcinoma
nlike  Paget’s  disease,  the  ulcerative  stage  of  breast
denocarcinoma  is  always  preceded  by  nipple  retraction
nd/or  ﬁxity.  Superﬁcial  spreading  occurs  at  a  clinically
ate  stage  (T4b)  and  requires  adapted  breast  examination
Fig.  9a—d).
Moreover,  17%  of  nipples  contain  lobules  and  can  there-
ore  be  the  initial  site  of  lobular  carcinoma  development
23].
ther rare differential diagnoses
yringomatous  adenoma  of  the  nipple  and  solitary  nipple
eiomyoma  are  other  rare  benign  nipple  tumors.  Borrelia-
ssociated  lymphocytoma  cutis  is  a  benign  condition  that
an  be  observed  after  a  tick  bite  on  the  nipple.  The
ollowing  malignant  tumors  have  also  been  described:
a (grade II NST-WHO 2012): a: erythematous, swollen nipple-areola
Mammography of the right breast (b, CC view; c, LM view): visible
uadrants, nipple retraction; d: breast MRI, axial subtracted phase
 the nipple showing rosette-like enhancement of its center.
Clinical  abnormalities  of  the  nipple-areola  complex  
basal  cell  epithelioma,  melanoma,  Bowen’s  disease  or  dis-
coid  lenticular  dyskeratosis,  spinous  cell  carcinoma,  and
leiomyosarcoma  [24].
Acquired inverted nipple
Introduction
From  the  semiologicial  point  of  view,  there  are  two  classes  of
inverted  nipple.  First,  congenital  inverted  nipple  for  which
there  are  two  subtypes:  invaginated  nipple  (reducible)  and
umbilicated  nipple  (irreducible).  Congenital  inverted  nip-
ples  are  observed  in  approximately  3%  of  women.  In  86%
of  patients  both  nipples  are  inverted.  Umbilicated  nipples
account  for  96.2%  of  cases  and  invaginated  nipples  for  3.8%
of  cases  [25].
The  second  class  is  acquired  nipple  inversion.  Again
there  are  two  distinct  forms  of  acquired  inverted  nipple:  a
retracted  nipple  is  only  partly  inverted,  whereas  an  invagi-
nated  nipple  is  completely  inverted.
Finally,  acute  and  chronic  forms  have  been  described,
the  commonly  accepted  maximum  duration  for  acute  forms
being  6  months.
Invagination  typically  occurs  at  puberty.  It  is  generally
due  to  a  variant  of  normal  development  with  ﬁbro-
sis  between  the  nipple  and  the  subareolar  parenchyma.
Patients  with  inverted  nipples  are  more  likely  to  suffer  from
mastitis  and  infectious  complications.
In  adult  women,  nipple  inversion  is  most  often  secondary
to  underlying  inﬂammatory  changes;  however  it  can  also  be
a  symptom  of  breast  carcinoma.
Benign causes of acute nipple
retraction/invagination
In  the  absence  of  a  palpable  mass,  nipple  inversion  is  rarely
associated  with  breast  carcinoma,  especially  in  women
under  50  years.  Clinically,  bilateral  nipple  inversion  that
is  stable  or  progresses  very  gradually  is  most  probably
benign  and  is  just  a  variant  of  normal  anatomy.  In  the  same
way,  central,  symmetric,  slit-like  nipple  inversion  is  usually
benign  (Fig.  10).
Figure 10. Bilateral, central, slit-like, benign inversion of the
nipple.
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uct ectasia of the breast
arly  stage  duct  ectasia  is  asymptomatic;  unilateral  milky  or
loody  discharge  is  then  observed  in  25%  of  patients.  It  can
ause  painful  subareolar  swelling  or  nipple  inversion.
Mammographic  ﬁndings  include  one  or  more  oblong,
ord-shaped  retroareolar  mass  of  water  density.  Duc-
al  calciﬁcations  are  sometimes  observed;  they  appear
olymorphic,  duct-shaped  with  regular  borders  and  are  ori-
ntated  towards  the  nipple.
The  ultrasound  ﬁndings  for  ectasia  are  well  established
ith  tubular  structures  containing  more  or  less  echogenic
aterial;  the  ﬁndings  are  sometimes  similar  to  ultrasound
mages  of  intraductal  tumor.  The  diagnosis  of  ectasia  can  be
onﬁrmed  by  the  visualization  of  moving  particles  within  the
ecretions.
MR  images  of  ductal  ectasia  show  tubular  structures
xhibiting  high  signal  intensity  on  T1-weighted  images,  due
o  the  presence  of  blood  products  or  proteinaceous  ﬂuid.
ontrast  enhancement  of  the  ductal  walls  may  also  be
bserved.
eriductal mastitis
eriductal  mastitis  usually  occurs  either  during  puberty  in
oung  women  with  congenital  invaginated  nipples,  or  in  per-
menopausal  women  without  congenital  invaginated  nipples.
t  seems  to  be  of  multifactorial  etiology.
The  clinical  signs  of  periductal  mastitis  depend  on  the
tage  of  the  disease.
Patients  with  acute  periductal  mastitis  present  with
reast  pain,  local  signs  of  inﬂammation,  and  sometimes
ipple  discharge  and/or  reversible  inversion.  The  patients
ometimes  experience  recurrent  episodes  of  acute  mastitis
hat  can  cause  infectious  complications  (abscess,  ﬁstula).
Chronic  mastitis  with  periductal  ﬁbrosis  causes  perma-
ent  nipple  inversion  and  its  clinical  signs  may  mimic  breast
arcinoma.
ther benign etiologies
ost-surgery  changes,  fat  necrosis,  ﬁbrocystic  changes,
uberculosis  and  Mondor’s  disease  [26]  can  also  cause
cquired  nipple  inversion.
reast carcinomas
pproximately  8%  of  breast  cancers  develop  within  the  cen-
ral  part  of  the  breast,  close  to  the  nipple-areola  complex
27]. Depending  on  studies,  5  to  50%  of  cases  of  invaginated
ipples  are  associated  with  malignancy  [28,29].
Some  tumors  arise  from  preexisting  intraductal  papillary
yperplasia  or  intraductal  papilloma.
From  a  clinical  point  of  view,  areolar  distortion  asso-
iated  with  nipple  invagination  is  most  often  due  to
alignancy  (Fig.  11a—d).
ecommended imaging studies in cases of
cute inversion nippleammography
wo-view  mammography  (CC  and  MLO  views)  should  be  per-
ormed  as  well  as  a  tangential  view  of  the  nipple  (with  a
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Figure 11. Malignant nipple retraction: a: irreducible retraction associated with lower quadrant ﬂattening and a palpable retroareolar
mass. Mammography of the left breast (b, CC view; c, LM view): spiculated mass showing microcalciﬁcations within its center and nipple
retraction; d: Breast ultrasound: retroareolar spiculated mass inﬁltrating the nipple-areola complex and nipple retraction. Pathology ﬁndings
after ultrasound-guided microbiopsy: grade II NST-WHO 2012.
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aarying  level  of  localization  and  with  or  without  radiopaque
ipple  markers)  in  order  to  detect  a  possible  retroareolar
ass.  Magniﬁed  views  should  also  be  obtained  in  both  CC
nd  MLO  views  to  visualize  microcalciﬁcations.
reast ultrasound
reast  ultrasound  is  used  to  characterize  clinical  and/or
ammographic  abnormalities.  Doppler  ultrasound  can  help
n  determining  the  nature  of  the  contents  of  ectatic  ducts
r  of  a  retroareolar  mass.  Ultrasound  should  be  performed
o  detect  mammographically  occult  lesions  if  no  abnormal-
ties  are  seen  on  the  mammograms,  especially  in  dense
reasts.
It  is  recommended  to  preheat  the  gel  used  to  avoid
he  contraction  of  the  smooth  muscle  ﬁbers  of  the  nipple-
reola  complex  which  might  attenuate  the  ultrasound
eam  posteriorly,  and  to  place  the  transducer  perpendic-
larly  to  the  main  ductal  axis  to  optimize  retroareolar
mages.
e
c
mreast MRI
reast  MRI  is  indicated  in  cases  that  are  difﬁcult  to  diagnose,
f  underlying  breast  carcinoma  is  suspected  but  not  detected
sing  mammography  or  ultrasound.
Another  more  controversial  indication  is  the  use  of  MRI
o  assess  whether  proven  breast  cancer  has  inﬁltrated  the
AC  or  not.  Indeed,  it  has  been  established  that  retroareolar
umors  and  tumors  located  close  to  the  nipple-areola  com-
lex  (at  less  than  20—25  mm),  a  tumor  of  more  than  2  cm  and
ymph  node/lymphovascular  invasion  [30]  are  predictors  of
AC  involvement.
Nipple  involvement  has  been  reported  to  occur  in  6—23%
f  patients  for  whom  it  was  clinically  unsuspected  [31,32].
n  the  recent  retrospective  study  by  Moon  et  al.  [33]  on
1  cancers  located  at  less  than  2 cm  from  the  NAC,  the
uthors  demonstrated  with  a  sensitivity  of  93.8%  that  NAC
nhancement  and  thickening  (>2  mm)  detected  by  MRI  were
orrelated  with  nipple  involvement.
The  sensitivity  of  MRI  seems  to  be  superior  to  that  of
ammography  for  the  diagnosis  and  assessment  of  nipple
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• Acquired  nipple  inversion  in  adult  women  is  generally
secondary  to  underlying  inﬂammatory  changes.
• However,  it  can  also  be  a  sign  of  breast  carcinoma,
especially  in  women  aged  over  50  and  if  a  palpable
mass  is  detected.
• When  the  initial  breast  examination  is  reassuring,
clinical  and  mammographic  follow-up  should  be
planned  at  close  intervals  over  a  1-year  period  or
until  clinical  stability  of  the  abnormality,  especially
in  patients  aged  over  50  years.
• If  in  doubt,  MRI  can  be  used  to  exclude  the
presence  of  underlying  cancer  and  reduce  monitoring
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gical  management?Clinical  abnormalities  of  the  nipple-areola  complex  
involvement  in  patients  with  retroareolar  breast  carci-
noma,  even  when  not  clinically  suspected  [34].  However,
the  results  of  the  retrospective  study  conducted  in  2013
by  Steen  et  al.  [35]  on  71  patients  were  less  in  favor  of
MRI  since  clinical  examination  combined  with  patient  ques-
tioning  performed  better  than  MRI  for  predicting  nipple
involvement  (sensitivity  of  61%  vs.  56%  respectively).  The
authors  suggested  that  this  conﬂicting  result  was  due  to  the
fact  that  screening  was  performed  at  an  earlier  stage  of
breast  cancer  when  nipple  involvement  is  often  limited  to
carcinoma  in  situ. MRI  therefore  seems  to  be  less  sensitive
than  anamnestic  and  clinical  data  for  detecting  carcinoma
in  situ  within  the  nipple.
Still,  some  authors  have  suggested  that  MRI  be  used  for
such  indications  prior  to  surgery  to  decrease  the  relapse  rate
when  breast-conserving  surgery  is  planned  [36].
Conclusion
Increased  clinician  awareness  is  called  for  when  patients
present  with  persistent  unilateral  nipple  lesions  and  the
possibility  of  Paget’s  disease  of  the  nipple  should  not  be
neglected.  Paget’s  disease  is  often  diagnosed  at  a  late
stage  although  only  a  simple  punch  biopsy  of  the  nipple  is
required.
Breast  mammography  and  ultrasound  should  be  per-
formed  systematically.  Due  to  the  high  rate  of  associated
breast  carcinoma  and  multifocality,  it  can  be  helpful  to  per-
form  breast  MRI  prior  to  surgery  if  breast-conserving  surgery
is  planned.
Recent  acquired  nipple  inversion  in  adult  women  is  gener-
ally  secondary  to  underlying  inﬂammatory  changes;  however
it  can  also  be  a  sign  of  breast  carcinoma,  especially  in  women
aged  over  50  and  if  a  palpable  mass  is  detected.
When  the  initial  breast  examination  is  reassuring,  clini-
cal  and  mammographic  follow-up  should  be  planned  at  close
intervals  over  a  1-year  period  or  until  clinical  stability  of
the  abnormality,  especially  in  patients  aged  over  50  years.
If  in  doubt,  MRI  can  be  used  to  exclude  the  presence  of
underlying  cancer  and  reduce  monitoring  frequencies.
TAKE-HOME  MESSAGES
• Persistent  unilateral  nipple  lesions  should  alert
clinicians  to  the  possible  diagnosis  of  Paget’s  disease
of  the  nipple.
• Paget’s  disease  is  diagnosed  histologically  by  punch
biopsy  or  scrape  cytology.
• It  is  associated  with  breast  carcinoma  in  more  than
80%  of  cases  with  a  high  frequency  of  multifocality/
multicentricity.
• The  histological  factors  of  cancer  associated  with
Paget’s  disease  are  often  of  poor  prognosis  and  the
survival  of  patients  with  Paget’s  disease  is  lower  than
that  of  patients  with  breast  cancer  without  Paget’s
disease.
• Pre-operative  breast  MRI  is  useful  if  breast-
conserving  surgery  is  planned.
Ffrequencies.
linical case
atient  aged  48  years,  pre-menopausal,  no  individual  or
amilial  history  of  breast  cancer,  who  attended  a  breast
creening  visit.  On  clinical  examination,  the  clinician
etected  a  lesion  of  the  right  nipple  (Fig.  12).  The  patient
ndicated  that  the  lesion  appeared  a  year  ago  and  had  not
rogressed  since.  Bilateral  mammograms  (Fig.  13a—b)  and
reast  ultrasound  images  were  categorized  as  BI-RADS  2
ACR).
Punch  biopsy  was  performed  and  conﬁrmed  a  diagnosis
f  Paget’s  disease  of  the  nipple  associated  with  retroareolar
CIS.
uestions
.  Describe  the  lesion.
. What  is  the  appropriate  management  of  this  patient?
.  Should  further  imaging  be  performed  before  referring  the
patient  to  the  surgeon?
.  What  breast  examination  should  be  carried  out  following
MRI?
.  Is  further  investigation  possible  prior  to  deciding  on  sur-igure 12. Lesion of the right nipple.
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Figure 14. Breast MRI, axial subtracted phase images at 2 minutes
30 seconds after injection of gadolinium: a: nipple-areola complex
enhancement and linear non-masslike retroareolar enhancementigure 13. Bilateral mammography (CC views): right (2a), left (2
nswers
.  Clearly  deﬁned  nipple  ulceration,  centered  on  the  nip-
ple,  scaly.
. Due  to  the  unilateral  and  chronic  nature  of  the  lesion,
Paget’s  disease  of  the  nipple  should  be  excluded  by  punch
biopsy  or  scrape  cytology.
.  Because  mammographic  and  ultrasound  ﬁndings  are  cat-
egorized  as  BI-RADS  2  (ACR),  breast  MRI  is  recommended
as  it  is  more  sensitive  for  detecting  associated  cancer
lesions.  Breast  MRI  was  performed  (Fig.  14a—b).
.  The  initial  mammograms  can  be  reexamined  to  detect
microcalciﬁcations  at  the  limit  of  visibility.  If  detected,
magniﬁed  images  of  the  boundary  between  lateral  quad-
rants  can  be  obtained  (Fig.  15a).  Targeted  ultrasound
should  also  be  performed  to  detect  a  lesion  consistent
with  MRI  ﬁndings  (Fig.  15b).  No  abnormalities  consistent
with  MRI  ﬁndings  were  detected  with  these  additional
examinations.  The  mammogram  and  ultrasound  images
of  the  right  breast  remain  categorized  as  BI-RADS  2
(ACR).
.  Due  to  the  high  risk  of  malignancy,  histological  results
are  essential.  In  such  cases  MRI-guided  biopsy  is  indicated
and  was  carried  out  on  this  patient  (Fig.  16a—c).  Another
possibility  would  be  to  obtain  pre-operative  MRI-guided
or  computed  tomography-guided  scout  images.  The  sam-
ples  collected  by  MRI-guided  biopsy  revealed  low-grade
DCIS.  Based  on  these  results,  the  pretreatment  multi-
disciplinary  coordination  meeting  decided  on  immediate
mastectomy  with  breast  reconstruction  without  sentinel
lymph  node  biopsy.  The  deﬁnitive  histological  results  on
the  tissue  removed  by  mastectomy  were  ‘‘Paget’s  dis-
ease  of  the  nipple  (size:  10  mm)  associated  with  DCIS
(size:  10  mm)  posteriorly  to  the  nipple;  absence  of  resid-
ual  carcinoma  on  the  biopsy  scar’’.
measuring approx. 1 cm consistent with biopsy results; b: magniﬁ-
cation of a 5-mm zone at the boundary between lateral quadrants,
in the central part of the breast.
Clinical  abnormalities  of  the  nipple-areola  complex  1043
Figure 15. Targeted breast examination: a: mammography of the right breast, LM view, enlarged image: absence of microcalciﬁcation
cluster(s); b: targeted breast ultrasound: no abnormalities detected in the targeted zone.
comp
ew; 
[Figure 16. MRI-guided biopsies: a: biopsy needle inserted into a 
gadolinium. Post-biopsy mammograms of the right breast (b, LM vi
consistent with that determined by MRI.
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